Discovering and developing innovative therapeutics for CNS disorders

Welcome to the Newron Pharmaceuticals website.
We are a clinical-stage biopharmaceutical company. Our shares are listed on the SWX Swiss Exchange (NWRN). Our mission is to discover, develop and commercialise novel drugs to treat diseases of the Central Nervous System (CNS) and pain.

Investors

Investor Contacts

Newron contacts:
Stefan Weber - CFO
Arianna Baldo - Assistant
Phone: +39 02 6103 46 30
E-mail: ir@newron.com